This resolution designates September 2025 as National Polycystic Kidney Disease Awareness Month to raise public awareness and understanding of PKD. It expresses support for the goals and ideals of the awareness month and highlights the PKD Foundation and its network of patient advocates as central to research, education, and caregiver support.
The bill frames PKD as a progressive, genetic disorder with multi-system impact and underscores the disease’s burden on health and finances, while calling for public observances to promote awareness and understanding.
At a Glance
What It Does
The bill designates September 2025 as National Polycystic Kidney Disease Awareness Month and expresses support for activities that raise awareness and understanding of PKD, including recognizing the PKD Foundation and its advocates.
Who It Affects
Directly relevant to PKD patients and their families, healthcare providers who educate about PKD, and patient advocacy organizations that coordinate awareness efforts and events.
Why It Matters
A formal recognition can mobilize education, outreach, and fundraising activities, helping to lift public understanding of PKD’s health and financial burden and to highlight ongoing research needs.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Polycystic kidney disease (PKD) is a progressive, genetic condition that damages the kidneys and related organ systems. The bill emphasizes that PKD affects roughly 600,000 people in the United States and notes the substantial clinical and financial burdens borne by patients and families, including the fact that about half of those diagnosed may develop kidney failure by age 60.
It also highlights that a significant portion of cases arise without a family history due to spontaneous mutations. The resolution designates September 2025 as National Polycystic Kidney Disease Awareness Month and calls for observances that raise public awareness and understanding of PKD, with particular emphasis on the PKD Foundation and its advocates who lead research, education, and support activities—such as the annual Walk for PKD.
While the resolution does not authorize funding, it signals congressional support for ongoing awareness and education efforts and for continued emphasis on PKD’s impact on individuals and families. The text frames awareness as a precursor to better care and increased attention to research needs, including pursuing a cure for PKD.
The Five Things You Need to Know
Designates September 2025 as National Polycystic Kidney Disease Awareness Month.
Frames PKD as a progressive genetic disorder with multi-system impacts and a substantial patient burden.
Cites the PKD Foundation and its 35,000 advocates as key partners in research, education, and support.
Calls for appropriate ceremonies and activities to promote public awareness and understanding of PKD.
Expresses support for further research to find a cure and for public awareness to reflect this urgency.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Designation of National PKD Awareness Month
This section establishes September 2025 as National Polycystic Kidney Disease Awareness Month. It formalizes a nationwide recognition intended to catalyze education and public engagement about PKD’s health and social impacts. By designating a calendar period, the clause creates a framework for coordinated observance without imposing new regulatory requirements on individuals or entities.
Goals and ideals of awareness efforts
This provision articulates the aims of PKD Awareness Month: to raise public awareness and deepen understanding of PKD and its effects on patients and families. It also foregrounds the need for ongoing research toward better treatments and ultimately a cure, tying awareness to the broader pursuit of scientific and clinical advances.
Support for advocacy and family-centered activities
The section acknowledges the PKD Foundation and its network of patient and family advocates as central to PKD work, including research, education, and support activities. It reinforces the idea that awareness observances should be complemented by events and campaigns—such as fundraising walks—that mobilize communities to support PKD research and patient care.
Call to participation and public engagement
The final substantive section urges all Americans and interested groups to participate in PKD Awareness Month through appropriate ceremonies and activities. The emphasis is on broad engagement to promote public awareness of PKD’s impact on individuals and families, reinforcing the message that awareness is a step toward better health outcomes and policy attention.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- PKD patients and their families gain greater visibility and potentially improved access to information, resources, and support related to PKD.
- The PKD Foundation and its 35,000 patient and family advocates gain formal recognition, strengthening partnerships for education, outreach, and fundraising.
- Healthcare providers and researchers specializing in PKD benefit from heightened awareness, which can facilitate patient education and collaboration with research initiatives.
- Community organizations and patient advocacy groups gain a lawful framework and national attention to coordinate local observances and educational activities.
Who Bears the Cost
- No explicit federal funding is authorized in the resolution; any costs associated with observances would be borne by participating organizations and private sponsors.
- Public health departments and healthcare institutions hosting events may incur minor, incidental costs to support observances.
- Media outlets and event organizers may incur costs to sponsor or cover awareness activities, though these costs are not mandated by the bill.
- Private philanthropies and patient advocacy groups would likely shoulder the bulk of fundraising and programmatic support associated with PKD awareness efforts.
Key Issues
The Core Tension
The central tension is between symbolic recognition and practical impact: can a designated month meaningfully accelerate PKD research, awareness, and patient support without dedicated funding or policy changes? The answer depends on voluntary actions by communities and organizations, and on the ability of advocates to convert awareness into tangible resources and care improvements.
The resolution is a symbolic, nonbinding expression of support that designates a month for PKD awareness and calls for related observances. It relies on private sector and nonprofit partnerships for implementation, since no funding or regulatory mandates accompany the designation.
As a result, the potential impact depends on how communities, healthcare providers, and advocacy organizations organize events, share information, and channel resources toward PKD education and research. The absence of a funding directive also means there is no guaranteed expansion of services or allocations for PKD treatment, research, or patient support, and outcomes will vary based on local capacity and private contributions.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.